When IVF emerged, it revolutionised reproductive healthcare by allowing infertile couples to have genetically related children. The rise of surrogacy added another layer of possibility, removing the often challenging physical demands of pregnancy.
The procedure has only grown more sophisticated with time, having significant implications for reproductive health and conception.
A recent groundbreaking study in the UK has created IVF embryos free from mitochondrial diseases that they could have potentially inherited.
Eight Healthy IVF Babies
In the aforementioned UK trial, women carrying life-threatening mitochondrial diseases were selected and given mitochondrial donation treatment via a complex three-parent IVF procedure.
The mother’s egg is fertilised by the father’s sperm. The nucleus is extracted from the fertilised egg and is transferred to a healthy donor egg with no nucleus.
The resulting embryo, with nuclear DNA from its parents and mitochondrial DNA from the healthy donor, is implanted into the uterus to establish pregnancy.
The first eight babies born were healthy at birth with absent or low levels of mutant mitochondria inherited from the mother. They are unlikely to develop mitochondrial diseases in the future.
However, a problem arises for mothers affected by varying levels of mutant mitochondria. For such women, pre-implantation genetic testing (PGT) can be used to select eggs with the lowest chances of disease transmission.
This trial has been life-altering for families whose generations could have been affected by lethal mitochondrial disease. A mother of one of the healthy IVF babies said:
“As parents, all we ever wanted was to give our child a healthy start in life. After years of uncertainty, this treatment gave us hope, and then it gave us our baby … we’re overwhelmed with gratitude. Science gave us a chance.”
Mitochondrial genetic diseases have a high disease burden, affecting 1 in every 5000 newborns. They are transmitted down the maternal line, meaning that affected mothers are likely to have affected children.
Such treatments offer hope to these families, helping them create and raise healthy children free from mitochondrial diseases.
A Leap Forward in the Prevention of Genetic Diseases
Mitochondrial DNA mutations can have catastrophic consequences because they primarily affect energy-demanding organs, such as the brain, heart, and muscles.
A foolproof and targeted prevention strategy against these diseases can help affected families avoid potentially debilitating and incurable diseases.
The UK trial was a success, but it requires careful oversight and strict regulation. Ongoing follow-ups will be essential to monitor the health and development of the children involved, and thoughtful ethical considerations must be addressed before introducing such procedures to the wider public.
Nonetheless, the trial has opened new doors and offered hope, reminding many that the future may be brighter than they once believed.
Stay tuned to Brandsynario for the latest news and updates.
